3/26/2010

Eisai decided not to seek early approval of sepsis treatment eritoran in the U.S., Japan and Europe, postponing its plan until March 2011. An independent committee previously recommended adding patients to a late-stage trial of the drug.

Full Story:
Reuters

Related Summaries